Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Pricing may vary based on your individualized dosage and program phase
Details are provided in the Methods section
Rybelsus (semaglutide) Tablets 3 mg provide an accessible and effective entry point for type 2 diabetes management, empowering patients with an impactful oral therapy option that fits seamlessly into daily routines under guidance from healthcare providers
Wiest, R
Head of Medical Affairs BSc (Hons), MSc, PhD Dr
The PIONEER 3 study (Effect of Additional Oral Semaglutide vs Sitagliptin on Glycated Hemoglobin in Adults With Type 2 Diabetes Uncontrolled With Metformin Alone or With Sulfonylurea: The PIONEER 3 Randomized Clinical Trial), consisting of 1864 subjects, tested the effectiveness of Rybelsus to Januvia (another DPP-4 inhibitor)
US$ 21.64
US$ 23.44
US$ 25.75
US$ 27.70
US$ 21.67
